arrow
D

Dario Baratti

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:60
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative oncological efficacy of chemotherapy, cytoreductive surgery with or without HIPEC in recurrent ovarian cancer: A network meta-analysis

化疗、减瘤术(含或不含HIPEC)治疗复发性卵巢癌的肿瘤学疗效比较:一项网络Meta分析

EJSO
IF2.9
2026-09-110
PRE
Tailoring HIPEC with Patient-Derived Organoids in Colorectal Peritoneal Metastases: Results from the First Stage of the Prospective Phase II OrganoHIPEC Clinical Trial (Clinicaltrials.gov NCT06057298)

利用患者源性类器官定制腹腔热灌注化疗(HIPEC)治疗结直肠癌腹膜转移:前瞻性II期OrganoHIPEC临床试验第一阶段的成果(Clinicaltrials.gov NCT06057298)

Cancers
IF4.4
2026-08-280
OA
FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic target

FASN在弥漫性恶性腹膜间皮瘤中的应用:CRS+HIPEC后的预后生物标志物和治疗靶点

2026-05-210
OA
ASO Visual Abstract: Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy-Results of Phase 1 of the PRECINCT Study in 707 Patients
2024-09-160
PRE
Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 Patients
2024-08-261
OAAI
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside (vol 43, 132, 2024)
2024-06-110
OAAI
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside
2024-05-026
OAAI
Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases

特定KRAS突变对结直肠腹膜转移患者的预后价值

2024-04-014
OAAI
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin
2023-12-013
PRE
ASO Visual Abstract: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis
2023-10-311
PRE